Unknown

Dataset Information

0

Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals.


ABSTRACT: Models created by the intraperitoneal injection of lipopolysaccharide (LPS) and D-galactosamine (D-GalN) have been widely used to study the pathogenesis of human acute liver failure (ALF) and drug development. Our previous study reported that oyster (Crassostrea gigas) hydrolysate (OH) had a hepatoprotective effect in LPS/D-GalN-injected mice. This study was performed to identify the hepatoprotective effect of the tyrosine-alanine (YA) peptide, the main component of OH, in a LPS/D-GalN-injected ALF mice model. We analyzed the effect of YA on previously known mechanisms of hepatocellular injury in the model. LPS/D-GalN-injected mice showed inflammatory, apoptotic, ferroptotic, and pyroptotic liver injury. The pre-administration of YA (10 mg/kg or 50 mg/kg) significantly reduced the liver damage factors. The hepatoprotective effect of YA was higher in the 50 mg/kg YA pre-administered group than in the 10 mg/kg YA pre-administered group. These results showed that YA had a hepatoprotective effect by reducing inflammation, apoptosis, ferroptosis, and pyroptosis in the LPS/D-GalN-injected ALF mouse model. We suggest that YA can be used as a functional peptide for the prevention of acute liver injury.

SUBMITTER: Siregar AS 

PROVIDER: S-EPMC8624370 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5468566 | biostudies-literature
| S-EPMC6174814 | biostudies-literature
| S-EPMC3000955 | biostudies-literature
2021-12-28 | GSE124473 | GEO
| S-EPMC7408007 | biostudies-literature
| S-EPMC3887435 | biostudies-literature
| S-EPMC8471683 | biostudies-literature
| S-EPMC10730122 | biostudies-literature
| S-EPMC3741496 | biostudies-literature
| S-EPMC9022797 | biostudies-literature